Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

WHO names new COVID variant omicron, cautions against travel measures

Published 26/11/2021, 12:13
Updated 26/11/2021, 19:10
© Reuters. A street hawker looks at her mobile phone as she sits next to her wares after the announcement of a British ban on flights from South Africa because of the detection of a new coronavirus disease (COVID-19) variant, in Soweto, South Africa, November 26, 20

By Stephanie Nebehay and Alexander Winning

GENEVA (Reuters) -The World Health Organisation (WHO) on Friday classified the B.1.1.529 variant detected in South Africa as a SARS-CoV-2 "variant of concern," saying it may spread more quickly than other forms.

Preliminary evidence suggested there is an increased risk of reinfection and there had been a "detrimental change in COVID-19 epidemiology," it said in a statement after a closed meeting of independent experts who reviewed the data.

Infections in South Africa had risen steeply in recent weeks, coinciding with detection of the variant now designated as omicron, WHO said.

"This variant has a large number of mutations, some of which are concerning. Preliminary evidence suggests an increased risk of reinfection with this variant, as compared to other (variants of concern), it said.

Omicron is the fifth variant to carry such a designation.

"This variant has been detected at faster rates than previous surges in infection, suggesting that this variant may have a growth advantage," the WHO said.

Current PCR tests continue to successfully detect the variant, it said.

Earlier, the WHO cautioned countries against hastily imposing travel restrictions linked to the variant of COVID-19, saying they should take a "risk-based and scientific approach".

Global authorities reacted with alarm to the new variant detected in South Africa, with the EU and Britain among those tightening border controls as scientists sought to find out if the mutation was vaccine-resistant. [L1N2SH089]

"At this point, implementing travel measures is being cautioned against," WHO spokesman Christian Lindmeier told a U.N. briefing in Geneva. "The WHO recommends that countries continue to apply a risk-based and scientific approach when implementing travel measures."

It would take several weeks to determine the variant's transmissibility and the effectiveness of vaccines and therapeutics against it, he said, noting that 100 sequences of the variant have been reported so far.

People should continue to wear masks whenever possible, avoid large gatherings, ventilate rooms and maintain hand hygiene, Lindmeier added.

Mike Ryan, WHO's emergency director, praised South African public health institutions for picking up the signal of the new variant.

© Reuters. A street hawker looks at her mobile phone as she sits next to her wares after the announcement of a British ban on flights from South Africa because of the detection of a new coronavirus disease (COVID-19) variant, in Soweto, South Africa, November 26, 2021. REUTERS/Siphiwe Sibeko

But he warned that while some countries had systems in place to do this, the situation elsewhere was often unclear.

"So it's really important that there are no knee-jerk responses here. Especially with relation to South Africa," he said. "Because we've seen in the past, the minute that there is any mention of any kind of variation, then everyone is closing borders and restricting travel."

Latest comments

WHO are useless, rather take chances asking a magic 8 ball
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.